Biospecimen Collection + Diagnostic Imaging Testing + Excisional Biopsy + Minimally Invasive Surgery + Pelvic Lymphadenectomy + Questionnaire Administration + Sentinel Lymph Node Mapping + Indocyanine Green for carcinosarcoma

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Dec 2022: Trial started, NCT05646316
  2. 12 Dec 2022: Trial registered, NCT05646316

The trials

NCT05646316: Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

State
Under way
Phase
Phase 3
People
428 planned
Started
7 Dec 2022
Primary completion
31 Mar 2029
Arms
Arm 1 (sentinel lymph node mapping), Arm 2 (sentinel lymph node mapping, pelvic lymphadenectomy)
Results
None posted
  1. 7 Dec 2022: Trial started
  2. 12 Dec 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.